Jeffrey Apple, MD
Surgery · Austin, TXNPI 1750354924
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.5%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Cook Incorporated at 53.1% of the total. Reporting peaked in 2022 at $15,748 and has fallen 79.3% since, to $3,256 in 2025. Among surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 259 payments — averaging $187.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Cook Incorporated$26K
- Silk Road Medical, Inc.$8K
- Medtronic$5K
- Cook Medical LLC$5K
- Penumbra, Inc.$936
- W. L. Gore & Associates, Inc.$883
- plus $3K from 24 others
Across 48 payments — averaging $3550.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Veryan Medical Incorporated$80K
- Silk Road Medical, Inc.$49K
- Bard Peripheral Vascular, Inc.$20K
- Boston Scientific$10K
- Cook Research Incorporated$8K
- Endologix LLC$4K
What the payments were for
- Consulting fees$7,15015%
- Speaking & faculty fees$24,50050%
- Travel & lodging$7,27815%
- Food & beverage$9,58920%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Cook Incorporated | 14 | $25,768 |
| Silk Road Medical, Inc. | 32 | $8,041 |
| Medtronic(2 entities) | 39 | $5,218 |
| Cook Medical LLC | 88 | $4,962 |
| Penumbra, Inc. | 17 | $936 |
| W. L. Gore & Associates, Inc. | 12 | $883 |
| Boston Scientific | 9 | $262 |
| Cvrx, Inc. | 5 | $257 |
| Atricure, Inc. | 2 | $207 |
| Terumo Medical Corporation | 3 | $191 |
| Shape Memory Medical Inc. | 2 | $189 |
| KARL Storz Endoscopy-america | 1 | $188 |
| Inspiremd Ltd | 1 | $186 |
| Bolton Medical Inc | 2 | $182 |
| BD | 2 | $167 |
| Johnson & Johnson(2 entities) | 2 | $146 |
| Bard Peripheral Vascular, Inc. | 7 | $139 |
| Stryker | 2 | $137 |
| Contego Medical, Inc | 2 | $110 |
| Lemaitre Vascular, Inc. | 3 | $75 |
| Abbott | 3 | $67 |
| Inari Medical, Inc. | 2 | $31 |
| Ossur Americas, Inc. | 2 | $31 |
| Shockwave Medical, Inc | 1 | $31 |
| Davol Inc. | 1 | $24 |
| Reflow Medical Inc | 1 | $21 |
| Philips North America LLC | 1 | $20 |
| Getinge USA Sales, LLC | 1 | $19 |
| Tactile Systems Technology Inc | 1 | $16 |
| Angiodynamics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilver Vena$23,560
- ENROUTE Transcarotid Neuroprotection System$7,960
- ENROUTE Transcarotid Stent$7,446
- Cook Celect$4,500
- ENROUTE .014 Guidewire$3,026
- ENHANCE Transcarotid Peripheral Access Kit$3,026
- ENDURANT IIS$2,859
- Zilver PTX$756
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$515
- Penumbra System$381
- C3 Delivery System$318
- Indigo System$289
- NEO Stream Connect$188
- CGuard Prime Carotid Stent System$186
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$177
- ATRICLIP LAA EXCLUSION SYSTEM$177
- Heli-FX EndoAnchor System$176
- ADVANCE$170
- Zilver 635$161
- IMPEDE EMBOLIZATION PLUG$139
How this compares
$48,517 in reported general payments places this provider in the 90th percentile of 1,830 surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 112 | $70,494 |
| XareltoRivaroxaban | 54 | $44,961 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 69 | $768 |
| ClopidogrelClopidogrel Bisulfate | 69 | $705 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $146 | $44,96154 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,830 surgery providers in Texas.
Other surgery in Austin
- Douglas StoddardAustin$1.4M
- Steven FassAustin$989K
- Vineet ChoudhryAustin$851K
- Nancy MarquezAustin$700K
- Alejandro EsquivelAustin$631K
- Francis BuzadAustin$198K
- Francis BuckleyAustin$169K
- Eric AchesonAustin$113K
- Michael HarkinsTomball$2.7M
- Andy HawthorneRound Rock$843K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.